Nano Pharmaceuticals
Market Cap
₹2 ₹2.00 Cr.
P/E
0.00
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
-0.93
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
30.82 %
Institutions
Institutions
0.96 %
Market cap
Market cap
2.00 Cr
No. of Shareholders
No. of Shareholders
1,482
OPM (%)
OPM (%)
-479 %
PE
PE
-
Prom Holding
Prom Holding
32.27 %
ROCE (%)
ROCE (%)
128
ROE (%)
ROE (%)
14.26
Sales
Sales
0.05 Cr
  • Cresanto Global
  • Fabino Enterprises
  • MPS Pharmaa
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      4
      52W Range
      High
      5
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      5 Yes

      Positive for this company

      2 Neutral

      Neutral for this company

      5 No

      Negative for this company

      5 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Peer Comparison

      FAQs on Cresanto Global Ltd. Business

      Raymed Labs Ltd specializes in the manufacturing of a diverse range of pharmaceutical products including antibiotics, anti-inflammatories, and other medications for both human and veterinary use.

      Cresanto Global major competitors are Fabino Enterprises, MPS Pharmaa, Zyden Gentec, Decipher Labs, Adline Chem Lab, Hemo Organic, Ganga Pharma.
      Market Cap of Cresanto Global is ₹2 Crs.
      While the median market cap of its peers are ₹6 Crs.

      Cresanto Global seems to be less financially stable compared to its competitors.
      Altman Z score of Cresanto Global is -1132.77 and is ranked 8 out of its 8 competitors.

      Company Filing

      2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
      Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
      Earnings Release
      Investor Presentation
      Conference Call
      Conference Call SummaryCon Call Summary

      Discussions & Analysis

      Ideas Dashboard
      Results
      Timeline
      Watchlist
      Portfolio
      Alerts
      Stock Screener
      Market
      Raw Material